1. Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis 
Jeffrey Hyams, Lakshmi Damaraju, Marion Blank, Jewel Johanns, Cynthia Guzzo, Harland S. Winter, Subra Kugathasan, Stanley Cohen, James Markowitz, Johanna C. Escher, Gigi Veereman–Wauters, Wallace Crandall, Robert Baldassano, Anne Griffiths 
Clinical Gastroenterology and Hepatology 
Volume 10, Issue 4, Pages e1 (April 2012)
DOI: /j.cgh
Copyright © 2012 AGA Institute Terms and Conditions

2. Figure 1 Patient disposition.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2012 AGA Institute Terms and Conditions

3. Figure 2
Median partial Mayo scores through week 54 (A). PUCAI clinical remission (B). Median average daily corticosteroid dose through week 54; randomized patients taking corticosteroids at baseline (C). Corticosteroid-free PUCAI clinical remission (D).
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2012 AGA Institute Terms and Conditions

4. Supplementary Figure 1
CONSORT flow diagram. IVRS, interactive voice response system.
Clinical Gastroenterology and Hepatology  , e1DOI: ( /j.cgh )
Copyright © 2012 AGA Institute Terms and Conditions